- Home
- GIGM vs PYPD Comparison
GIGM vs PYPD Comparison
Compare GIGM & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIGM
- PYPD
- Stock Information
- Founded
- GIGM 1998
- PYPD 2008
- Country
- GIGM Taiwan
- PYPD Israel
- Employees
- GIGM N/A
- PYPD N/A
- Industry
- GIGM Computer Software: Programming Data Processing
- PYPD Medical/Dental Instruments
- Sector
- GIGM Technology
- PYPD Health Care
- Exchange
- GIGM Nasdaq
- PYPD Nasdaq
- Market Cap
- GIGM 17.0M
- PYPD 34.8M
- IPO Year
- GIGM 2000
- PYPD 2020
- Fundamental
- Price
- GIGM $1.81
- PYPD $3.46
- Analyst Decision
- GIGM
- PYPD Strong Buy
- Analyst Count
- GIGM 0
- PYPD 5
- Target Price
- GIGM N/A
- PYPD $12.00
- AVG Volume (30 Days)
- GIGM 22.4K
- PYPD 52.0K
- Earning Date
- GIGM 10-29-2025
- PYPD 11-12-2025
- Dividend Yield
- GIGM N/A
- PYPD N/A
- EPS Growth
- GIGM N/A
- PYPD N/A
- EPS
- GIGM N/A
- PYPD N/A
- Revenue
- GIGM $3,250,000.00
- PYPD N/A
- Revenue This Year
- GIGM N/A
- PYPD N/A
- Revenue Next Year
- GIGM N/A
- PYPD N/A
- P/E Ratio
- GIGM N/A
- PYPD N/A
- Revenue Growth
- GIGM N/A
- PYPD N/A
- 52 Week Low
- GIGM $1.30
- PYPD $2.30
- 52 Week High
- GIGM $1.89
- PYPD $3.93
- Technical
- Relative Strength Index (RSI)
- GIGM 62.31
- PYPD 51.28
- Support Level
- GIGM $1.61
- PYPD $3.35
- Resistance Level
- GIGM $1.89
- PYPD $3.54
- Average True Range (ATR)
- GIGM 0.09
- PYPD 0.11
- MACD
- GIGM 0.02
- PYPD -0.00
- Stochastic Oscillator
- GIGM 71.43
- PYPD 55.88
About GIGM GigaMedia Limited
GigaMedia Ltd is a diversified provider of digital entertainment services. Its only segment and principal business is digital entertainment service business, which operates a portfolio of digital entertainment products, targeting digital entertainment service users across Asia. It operates digital entertainment business in Taiwan, Hong Kong and Macau through FunTown.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.